reports
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Amgen Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 16 July 2025 in which we reassessed the appropriateness of the ratings in the context of the rel...
- Pierre FerraguÊ
- Research Team ACF
ACF Thematic Oncology Lung Cancer Cough LCC 25042025
Lung Cancer Cough (LCC) is an under-served, perhaps unserved therapeutic subsegment of the Lung Cancer/Oncology market. 57-65% of early diagnosis lung cancer patients suffer from LCC, it is a highly debilitating condition. The US lung cancer therapeutics market consensus values range from ~USD 29.9bn in 2023 to ~USD 71.3bn in 2034, suggesting a compound annual growth rate (CAGR) of 8.2% over our 10 year forecast period. LCC is a prevalent symptom among lung cancer patients, and its management is...
Moody's Ratings affirms Amgen's Baa1 ratings; revises outlook to stabl...
Moody's Ratings (Moody's) affirmed the ratings of Amgen Inc. (Amgen) including the Baa1 senior unsecured notes rating, (P)Baa1 senior unsecured shelf rating, (P)Baa1 senior unsecured medium term note program rating, and Prime-2 commercial paper rating. At the same time, we revised Amgen's outlook to...
Moody's announces completion of a periodic review of ratings of Amgen ...
Moody's Ratings has completed a periodic review of the ratings of Amgen Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 7 March 2024 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant...
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 06-Oct-2023 / 13:34 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 05-Oct-2023 / 13:44 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 04-Oct-2023 / 13:46 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 03-Oct-2023 / 13:28 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
- Jonathan Moreland
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
DG DOLLAR GENERAL CORPORATION
ASTI ASCENT SOLAR TECHNOLOGIES
SLNO INC.
MPB SOLENO THERAPEUTICS INC
ZM MID PENN BANCORP INC.
PRCH ZOOM VIDEO COMMUNICATIONS
NRGX INC.
GNSS PORCH GROUP INC (A)
DSGN PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
GENASYS INC
DESIGN THERAPEUTICS INC
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
The Vanguard Group, Inc. (IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 02-Oct-2023 / 14:07 GMT/BST Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Full name of discloser The Vanguard Group, Inc. Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nom...
- Jonathan Moreland
PSEC PROSPECT CAPITAL CORPORATION
NWBI NORTHWEST BANCSHARES INC.
MPAA MOTORCAR PARTS OF AMERICA INC.
MEI METHODE ELECTRONICS INC.
LGND LIGAND PHARMACEUTICALS INCORPORATED
HZNP HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
GLP GLOBAL PARTNERS LP
DLTR DOLLAR TREE INC.
CFFN CAPITOL FEDERAL FINANCIAL INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
AAP ADVANCE AUTO PARTS INC.
OFIX ORTHOFIX INTERNATIONAL N.V.
VIRT VIRTU FINANCIAL INC. CLASS A
BR BROADRIDGE FINANCIAL SOLUTIONS INC.
GAM GENERAL AMERICAN INVESTORS CO. INC.
ENPH ENPHASE ENERGY INC.
FMC FMC CORPORATION
PAGP PLAINS GP HOLDINGS LP CLASS A
CSBR CHAMPIONS ONCOLOGY
HAIN THE HAIN CELESTIAL GROUP
UBFO INC.
IOVA UNITED SECURITY BANCSHARE
CMP IOVANCE BIOTHERAPEUTICS INC
SLNO COMPA SA
CDMO SOLENO THERAPEUTICS INC
CNX AVID BIOSERVICES
BWB CONSOL ENERGY INC.
LOVE BRIDGEWATER BANCSHARES
HGBL LOVESAC
HQL HERITAGE GLOBAL
HQH TEKLA LIFE SCIENCES INVESTORS
HPK H&Q HEALTHCARE INVESTORS
SLQT HIGHPEAK ENERGY INC (A)
PRCH SELECTQUOTE
ABCL INC.
NRGX PORCH GROUP INC (A)
RBLX ABCELLERA BIOLOGICS
TKNO PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
TSE ROBLOX
SONM ALPHA TEKNOVA
SOL INC.
GATO TRINSEO PLC
MEIP SONIM TECHNOLOGIES INC
TTOO RENESOLA LTD
SUNSHINE SILVER MINING AND REFINING CORP
MEI PHARMA INC.
T2 BIOSYSTEMS INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.